Glenmark launches anti viral drug Favipiravir at Rs 103 to treat mild COVID-19 cases

New Delhi, June 21: Drug firm Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a price of about Rs 103 per tablet.

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/3ewzqJK

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post